163 related articles for article (PubMed ID: 24828043)
1. Cancer: Darwinian tumour suppression.
Moreno E
Nature; 2014 May; 509(7501):435-6. PubMed ID: 24828043
[No Abstract] [Full Text] [Related]
2. "Darwinian" tumor-suppression model unsupported in clinical experience.
Qasim W; Gaspar HB; Thrasher AJ
Mol Ther; 2014 Sep; 22(9):1562-3. PubMed ID: 25186557
[No Abstract] [Full Text] [Related]
3. Leukaemia: competition can be a good thing.
Seton-Rogers S
Nat Rev Cancer; 2014 Jun; 14(6):381. PubMed ID: 24854070
[No Abstract] [Full Text] [Related]
4. Cell competition is a tumour suppressor mechanism in the thymus.
Martins VC; Busch K; Juraeva D; Blum C; Ludwig C; Rasche V; Lasitschka F; Mastitsky SE; Brors B; Hielscher T; Fehling HJ; Rodewald HR
Nature; 2014 May; 509(7501):465-70. PubMed ID: 24828041
[TBL] [Abstract][Full Text] [Related]
5. Early T cell differentiation lessons from T-cell acute lymphoblastic leukemia.
Tremblay CS; Hoang T; Hoang T
Prog Mol Biol Transl Sci; 2010; 92():121-56. PubMed ID: 20800819
[TBL] [Abstract][Full Text] [Related]
6. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.
García-Ramírez I; Bhatia S; Rodríguez-Hernández G; González-Herrero I; Walter C; González de Tena-Dávila S; Parvin S; Haas O; Woessmann W; Stanulla M; Schrappe M; Dugas M; Natkunam Y; Orfao A; Domínguez V; Pintado B; Blanco O; Alonso-López D; De Las Rivas J; Martín-Lorenzo A; Jiménez R; García Criado FJ; García Cenador MB; Lossos IS; Vicente-Dueñas C; Borkhardt A; Hauer J; Sánchez-García I
EMBO J; 2018 Jul; 37(14):. PubMed ID: 29880602
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.
Zhang J; Wang J; Liu Y; Sidik H; Young KH; Lodish HF; Fleming MD
Blood; 2009 Feb; 113(6):1304-14. PubMed ID: 19066392
[TBL] [Abstract][Full Text] [Related]
8. Somatic inactivation of ATM in hematopoietic cells predisposes mice to cyclin D3 dependent T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; DeMicco A; Bassing CH
Cell Cycle; 2015; 14(3):388-98. PubMed ID: 25659036
[TBL] [Abstract][Full Text] [Related]
9. Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL.
Cui Y; Onozawa M; Garber HR; Samsel L; Wang Z; McCoy JP; Burkett S; Wu X; Aplan PD; Mackall CL
Blood; 2015 May; 125(19):2958-67. PubMed ID: 25814528
[TBL] [Abstract][Full Text] [Related]
10. T cell lymphoblastic leukaemia/lymphoma associated with a microenvironment of thymic asteroid B cells in the bone marrow.
Naresh KN; May PC; Reid AG; Marks AJ; Macdonald D; Kanfer E
Histopathology; 2010 Oct; 57(4):549-54. PubMed ID: 20875071
[TBL] [Abstract][Full Text] [Related]
11. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
[TBL] [Abstract][Full Text] [Related]
12. Distinct requirements of hematopoietic stem cell activity and Nras G12D signaling in different cell types during leukemogenesis.
Wang J; Liu Y; Tan LX; Lo JC; Du J; Ryu MJ; Ranheim EA; Zhang J
Cell Cycle; 2011 Sep; 10(17):2836-9. PubMed ID: 21857161
[TBL] [Abstract][Full Text] [Related]
13. A regeneration computer model of the thymus.
Lumb JR
Comput Biomed Res; 1975 Aug; 8(4):379-92. PubMed ID: 1080455
[No Abstract] [Full Text] [Related]
14. Oncogenic Kras initiates leukemia in hematopoietic stem cells.
Sabnis AJ; Cheung LS; Dail M; Kang HC; Santaguida M; Hermiston ML; Passegué E; Shannon K; Braun BS
PLoS Biol; 2009 Mar; 7(3):e59. PubMed ID: 19296721
[TBL] [Abstract][Full Text] [Related]
15. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
[TBL] [Abstract][Full Text] [Related]
16. Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor.
Aifantis I; Mandal M; Sawai K; Ferrando A; Vilimas T
Immunol Rev; 2006 Feb; 209():159-69. PubMed ID: 16448541
[TBL] [Abstract][Full Text] [Related]
17. Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.
Cramer SD; Hixon JA; Andrews C; Porter RJ; Rodrigues GOL; Wu X; Back T; Czarra K; Michael H; Cam M; Chen J; Esposito D; Senkevitch E; Negi V; Aplan PD; Li W; Durum SK
Leukemia; 2018 Aug; 32(8):1795-1882. PubMed ID: 29535426
[No Abstract] [Full Text] [Related]
18. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation.
Wada T; Koyama D; Kikuchi J; Honda H; Furukawa Y
Blood; 2015 Jun; 125(24):3731-46. PubMed ID: 25904247
[TBL] [Abstract][Full Text] [Related]
19. The T-ALL paradox in cancer.
Hoang T; Hoang T
Nat Med; 2010 Nov; 16(11):1185-6. PubMed ID: 21052064
[No Abstract] [Full Text] [Related]
20. The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia.
Curtis DJ; McCormack MP
Clin Cancer Res; 2010 Dec; 16(23):5618-23. PubMed ID: 20861166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
